Palisade Bio Announces $5.2M Investment by the Yuma Regional Medical Center
August 20, 2021 09:25 ET
|
Palisade Bio, Inc.
$5.2M invested at $3.45 stock priceFunds to be used to advance clinical development of LB1148Investment driven by Phase 2 clinical data that the medical center believes may lead to LB1148 being used...